加载中........
×

MedSci 2019年期刊智能查询系统(2018年度)

期刊关键词: 支持模糊智能搜索,多关键词组合

期刊领域: 可留空

IF范围: 小于 大于 填数字,填写自己想选择的杂志影响因子范围,可留空

排列方式: 文章数量往往与发表的周期有关

注册会员 APP首发更新 在线咨询

    以下是对 ELIFE 杂志介绍
    缩写名/全名
    ISSN号 2050-084X
    被收录情况 Science Citation Index Expanded
    BIOSIS Previews
    出版周期 Irregular
    H指数 74 (google发布,2017年度)
    CiteScore分区 所属分类:Biochemistry, Genetics and Molecular Biology - General Biochemistry, Genetics and Molecular Biology 分区: 14/189|Neuroscience - General Neuroscience 分区: 9/111|Immunology and Microbiology - General Immunology and Microbiology 分区: 7/4
    CiteScore趋势 6.99 (2018年度)
    APP下载
    相关报道 · elife:三大顶级医学期刊随机对照试验分析:近400项研究结论被推翻,心血管疾病最常见
    · elife:干细胞技术为骨愈合带来了好消息
    · eLife:丙型肝炎动物模型的研究进展
    · 做超声发现“二尖瓣、三尖瓣少量反流”,可怕吗?需要治疗吗?
    · eLife:全局DNA甲基化重塑技术帮助检验体外实验模型是否有效
    · Elife:操纵CRISPR/Cas9“驯化”寄生虫病
    · eLife:血管生长是脂肪组织健康的关键
    · eLife:研究揭示尼古丁与酒精对大脑作用呈相反异常模式
    · Elife:科学家有望开发出治疗高血压的新型靶向性药物疗法
    · eLife:拷贝数改变负荷可作为多种癌症的预后指标
    出版社或管理机构杂志由  eLife Sciences Publications  出版或管理。    ISSN号:2050-084X
    杂志简介/稿件收录要求Aims & scope
    eLife publishes outstanding research in the life sciences and biomedicine, from the most fundamental and theoretical work, through to translational, applied, and clinical research. Our 32 Senior editors and 282-member Board of Reviewing Editors are among the most respected and accomplished individuals in their fields – from human genetics and neuroscience to biophysics and epidemiology. Where necessary, our Senior editors will also consult with external guest editors to evaluate new submissions.

    接收领域

    BIOCHEMISTRY
    BIOPHYSICS AND STRUCTURAL BIOLOGY
    CANCER BIOLOGY
    CELL BIOLOGY
    COMPUTATIONAL AND SYSTEMS BIOLOGY
    DEVELOPMENTAL BIOLOGY AND STEM CELLS
    ECOLOGY
    EPIDEMIOLOGY AND GLOBAL HEALTH
    GENES AND CHROMOSOMES
    GENOMICS AND EVOLUTIONARY BIOLOGY
    HUMAN BIOLOGY AND MEDICINE
    IMMUNOLOGY
    MICROBIOLOGY AND INFECTIOUS DISEASE
    NEUROSCIENCE
    PLANT BIOLOGY

    2015年数据:

    DAYS TO INITIAL DECISION ----4 days

    DAYS TO POST-REVIEW DECISION ---33 days

    DAYS SUBMISSION TO ACCEPTANCE----116 days

    At eLife, we’ve taken a fresh approach to peer review to save you time, and to provide clear direction and constructive input. Decisions are quick and efficient; revision requests are designed to be clear and manageable; and multiple rounds of revision are usually avoided. Here’s how it works:

    Initial decisions are delivered quickly

    Our Senior editors decide whether initial submissions are appropriate for in-depth peer review, usually in consultation with members of the Board of Reviewing Editors.

    Active scientists make all decisions

    A Senior editor assigns a member of the Board of Reviewing Editors to oversee the peer-review process. The Reviewing editor usually reviews the article him or herself, calling on one or two additional reviewers as needed.

    Revision requests are consolidated

    Reviewers get together online to discuss their recommendations, refining their feedback, and striving to provide clear and concise guidance. If the work needs essential revisions before it can be published, the Reviewing editor incorporates those requirements into a single set of instructions.

    Limited rounds of revision

    Additional rounds of revision are largely eliminated, as the Reviewing editor is able to assess most revised submissions without further outside review.

    Decisions and responses are available for all to read

    In the interests of openness and transparency we publish the most substantive parts of the decision letter after review and the associated author responses.




    杂志主页/投稿链接ELIFE 主页  (点击8686次)  | 投稿链接(点击3072次)
    常用链接

    免费全文(pubmed central) | 投稿经验 | Medsci期刊指数 | 杂志主页 | 投稿链接 |

    web对话